MAU2

Across TCGA pan-cancer cohorts, MAU2 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MAU2’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where MAU2 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types MAU2 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

CCRCC, LSCC, and HNSC are the cancer types where MAU2 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MAU2 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	All	+0.332	<.001	10	view →
LSCC	Male	All	+0.158	<.001	4	view →
HNSC	Male	All	+0.136	.001	4	view →
LUAD	All	All	−0.069	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MAU2–CCRCC

Open the CCRCC breakdown →